Clinical Trials of Metastatic Castration-sensitive Prostate Cancer: Recent Progress and New Horizons

Anis A. Hamid, Michael J. Morris, Ian D. Davis

Research output: Contribution to journalArticleOtherpeer-review

2 Citations (Scopus)


Recent clinical trials have changed the treatment landscape for metastatic castration-sensitive prostate cancer. Ongoing and future studies using new therapeutic approaches hold the promise of further improving outcomes for patients with advanced prostate cancer.

Original languageEnglish
Pages (from-to)165-167
Number of pages3
JournalEuropean Urology Focus
Issue number2
Publication statusPublished - 1 Mar 2019

Cite this